Relationship between Factor XII deficiency and thrombosis: the debate is still open?

2009 ◽  
Vol 27 (4) ◽  
pp. 456-457 ◽  
Author(s):  
Gianfranco Lessiani ◽  
Angela Falco ◽  
Elvira Nicolucci ◽  
Giancarlo Rolandi ◽  
Giovanni Davì
2014 ◽  
Vol 45 (1) ◽  
pp. 13-18
Author(s):  
Harumichi ITOH ◽  
Tomoya HARAGUCHI ◽  
Kazuhito ITAMOTO ◽  
Kinya TAMURA ◽  
Satoshi KANBAYASHI ◽  
...  

Author(s):  
Adeel Arshad ◽  
Nazia Mohamed ◽  
Absia Jabbar ◽  
Makiko Ban-hoefen

2002 ◽  
Vol 73 (1) ◽  
pp. 286-288 ◽  
Author(s):  
Tomomi Hasegawa ◽  
Masahisa Uematsu ◽  
Takuro Tsukube ◽  
Yukihiro Takemura ◽  
Yutaka Okita

1993 ◽  
Vol 67 (2) ◽  
pp. 95-99 ◽  
Author(s):  
U. Jaeger ◽  
S. Kapiotis ◽  
I. Pabinger ◽  
E. Puchhammer ◽  
P. A. Kyrle ◽  
...  

2018 ◽  
Vol 107 (4) ◽  
pp. 436-441 ◽  
Author(s):  
Anqing Zou ◽  
Mingshan Wang ◽  
Yanhui Jin ◽  
Xiaoli Cheng ◽  
Kankan Su ◽  
...  

2019 ◽  
Vol 32 (4) ◽  
pp. 596-598
Author(s):  
Hussien Elsiesy ◽  
Mohamed Shawakat ◽  
Waleed Alhamoudi ◽  
Mohamed Alsebayel ◽  
John Renz ◽  
...  

1981 ◽  
Author(s):  
D Roberts ◽  
O Hayne ◽  
E Fraser

We studied 15 members, in 3 generations of a family in whom the propositus had complete factor XII deficiency. The parents had factor XII levels of 59% and 62%. Three of the siblings had factor XII levels of less than 1%. Three more had factor XII levels of (30±5%). In 3 the levels ranged from (60-87%) and the remaining 2 siblings had levels exceeding 100%. The propositus with a level of less than 1% gave rise to an offspring with a level of 48%.We propose that the gene controlling factor XII production consists of 3 separate alleles expressed codominantly: A - normal, B - low, O - absent. Members of the family with 100% factor XII activity have genotype AA; those with less than 1% activity have genotype OO; subjects with levels of 30% have genotype BO, and those with levels of 60% have genotype AO. We feel our study sheds new light on the inheritance of factor XII and the wide variation of levels in the general population.


Toxins ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 79
Author(s):  
Benedito C. Prezoto ◽  
Nancy Oguiura

The sensitivity of vertebrate citrated plasma to pro- and anticoagulant venom or toxins occurs on a microscale level (micrograms). Although it improves responses to agonists, recalcification triggers a relatively fast thrombin formation process in mammalian plasma. As it has a natural factor XII deficiency, the recalcification time (RT) of chicken plasma (CP) is comparatively long [≥ 1800 seconds (s)]. Our objective was to compare the ability of bee venom phospholipase A2 (bvPLA2) to neutralize clot formation induced by an activator of coagulation (the aPTT clot) in recalcified human and chicken plasmas, through rotational thromboelastometry. The strategy used in this study was to find doses of bvPLA2 that were sufficient enough to prolong the clotting time (CT) of these activated plasmas to values within their normal RT range. The CT of CP was prolonged in a dose-dependent manner by bvPLA2, with 17 ± 2.8 ng (n = 6) being sufficient to displace the CT values of the activated samples to ≥ 1800 s. Only amounts up to 380 ± 41 ng (n = 6) of bvPLA2 induced the same effect in activated human plasma samples. In conclusion, the high sensitivity of CP to agonists and rotational thromboelastometry could be useful. For example, during screening procedures for assaying the effects of toxins in several stages of the coagulation pathway, such as clot initiation, formation, stability, strength, or dissolution.


Sign in / Sign up

Export Citation Format

Share Document